Lehmann R et al. |
Successful simultaneous islet-kidney transplantation using a steroid-free immunosuppression: two-year follow-up. |
2004 |
Am. J. Transplant. |
pmid:15196070
|
Kim EJ et al. |
Costimulation blockade alters germinal center responses and prevents antibody-mediated rejection. |
2014 |
Am. J. Transplant. |
pmid:24354871
|
Kandaswamy R et al. |
A prospective randomized trial of steroid-free maintenance regimens in kidney transplant recipients--an interim analysis. |
2005 |
Am. J. Transplant. |
pmid:15888064
|
Xu H et al. |
The allo- and viral-specific immunosuppressive effect of belatacept, but not tacrolimus, attenuates with progressive T cell maturation. |
2014 |
Am. J. Transplant. |
pmid:24472192
|
Qazi Y et al. |
Efficacy and Safety of Everolimus Plus Low-Dose Tacrolimus Versus Mycophenolate Mofetil Plus Standard-Dose Tacrolimus in De Novo Renal Transplant Recipients: 12-Month Data. |
2017 |
Am. J. Transplant. |
pmid:27775865
|
Coghill AE et al. |
Immunosuppressive Medications and Squamous Cell Skin Carcinoma: Nested Case-Control Study Within the Skin Cancer after Organ Transplant (SCOT) Cohort. |
2016 |
Am. J. Transplant. |
pmid:26824445
|
Zafrani L et al. |
Incidence, risk factors and clinical consequences of neutropenia following kidney transplantation: a retrospective study. |
2009 |
Am. J. Transplant. |
pmid:19538494
|
Krämer BK et al. |
Tacrolimus once daily (ADVAGRAF) versus twice daily (PROGRAF) in de novo renal transplantation: a randomized phase III study. |
2010 |
Am. J. Transplant. |
pmid:20840480
|
TruneÄka P et al. |
Once-daily prolonged-release tacrolimus (ADVAGRAF) versus twice-daily tacrolimus (PROGRAF) in liver transplantation. |
2010 |
Am. J. Transplant. |
pmid:20840481
|
Mehra MR et al. |
Immunosuppression in cardiac transplantation: science, common sense and the heart of the matter. |
2006 |
Am. J. Transplant. |
pmid:16686745
|
Grimm M et al. |
Superior prevention of acute rejection by tacrolimus vs. cyclosporine in heart transplant recipients--a large European trial. |
2006 |
Am. J. Transplant. |
pmid:16686762
|
Budde K et al. |
Novel once-daily extended-release tacrolimus (LCPT) versus twice-daily tacrolimus in de novo kidney transplants: one-year results of Phase III, double-blind, randomized trial. |
2014 |
Am. J. Transplant. |
pmid:25278376
|
Sis B et al. |
Reproducibility studies on arteriolar hyaline thickening scoring in calcineurin inhibitor-treated renal allograft recipients. |
2006 |
Am. J. Transplant. |
pmid:16686769
|
Böhmig GA et al. |
Immunoadsorption in severe C4d-positive acute kidney allograft rejection: a randomized controlled trial. |
2007 |
Am. J. Transplant. |
pmid:17109725
|
Budde K et al. |
Sotrastaurin, a novel small molecule inhibiting protein kinase C: first clinical results in renal-transplant recipients. |
2010 |
Am. J. Transplant. |
pmid:20121745
|
Bouamar R et al. |
Tacrolimus predose concentrations do not predict the risk of acute rejection after renal transplantation: a pooled analysis from three randomized-controlled clinical trials(†). |
2013 |
Am. J. Transplant. |
pmid:23480233
|
Busque S et al. |
The PROMISE study: a phase 2b multicenter study of voclosporin (ISA247) versus tacrolimus in de novo kidney transplantation. |
2011 |
Am. J. Transplant. |
pmid:21943027
|
Hamdy AF et al. |
Comparison of sirolimus with low-dose tacrolimus versus sirolimus-based calcineurin inhibitor-free regimen in live donor renal transplantation. |
2005 |
Am. J. Transplant. |
pmid:16162204
|
Kaufman DB et al. |
Alemtuzumab induction and prednisone-free maintenance immunotherapy in kidney transplantation: comparison with basiliximab induction--long-term results. |
2005 |
Am. J. Transplant. |
pmid:16162205
|
Naesens M et al. |
Tacrolimus exposure and evolution of renal allograft histology in the first year after transplantation. |
2007 |
Am. J. Transplant. |
pmid:17608835
|
Schwarz A et al. |
Polyoma virus nephropathy in native kidneys after lung transplantation. |
2005 |
Am. J. Transplant. |
pmid:16162212
|
Shemesh E et al. |
The Medication Level Variability Index (MLVI) Predicts Poor Liver Transplant Outcomes: A Prospective Multi-Site Study. |
2017 |
Am. J. Transplant. |
pmid:28321975
|
Muthusamy AS et al. |
Alemtuzumab induction and steroid-free maintenance immunosuppression in pancreas transplantation. |
2008 |
Am. J. Transplant. |
pmid:18828772
|
Van Laecke S et al. |
Posttransplantation hypomagnesemia and its relation with immunosuppression as predictors of new-onset diabetes after transplantation. |
2009 |
Am. J. Transplant. |
pmid:19624560
|
Pirenne J et al. |
Tolerance of liver transplant patients to strenuous physical activity in high-altitude. |
2004 |
Am. J. Transplant. |
pmid:15023147
|
Heisel O et al. |
New onset diabetes mellitus in patients receiving calcineurin inhibitors: a systematic review and meta-analysis. |
2004 |
Am. J. Transplant. |
pmid:15023151
|
Hardinger KL et al. |
Pharmacokinetics of tacrolimus in kidney transplant recipients: twice daily versus once daily dosing. |
2004 |
Am. J. Transplant. |
pmid:15023155
|
Suwelack B et al. |
Withdrawal of cyclosporine or tacrolimus after addition of mycophenolate mofetil in patients with chronic allograft nephropathy. |
2004 |
Am. J. Transplant. |
pmid:15023160
|
Diaz-Siso JR et al. |
Initial experience of dual maintenance immunosuppression with steroid withdrawal in vascular composite tissue allotransplantation. |
2015 |
Am. J. Transplant. |
pmid:25777324
|
Rodriguez-Rodriguez AE et al. |
The higher diabetogenic risk of tacrolimus depends on pre-existing insulin resistance. A study in obese and lean Zucker rats. |
2013 |
Am. J. Transplant. |
pmid:23651473
|
Klintmalm GB et al. |
Belatacept-based immunosuppression in de novo liver transplant recipients: 1-year experience from a phase II randomized study. |
2014 |
Am. J. Transplant. |
pmid:25041339
|
Momper JD et al. |
The impact of conversion from prograf to generic tacrolimus in liver and kidney transplant recipients with stable graft function. |
2011 |
Am. J. Transplant. |
pmid:21714845
|
TruneÄŒka P et al. |
Renal Function in De Novo Liver Transplant Recipients Receiving Different Prolonged-Release Tacrolimus Regimens-The DIAMOND Study. |
2015 |
Am. J. Transplant. |
pmid:25707487
|
Adam R et al. |
Improved survival in liver transplant recipients receiving prolonged-release tacrolimus in the European Liver Transplant Registry. |
2015 |
Am. J. Transplant. |
pmid:25703527
|
Oetting WS et al. |
Genomewide Association Study of Tacrolimus Concentrations in African American Kidney Transplant Recipients Identifies Multiple CYP3A5 Alleles. |
2016 |
Am. J. Transplant. |
pmid:26485092
|
Badri P et al. |
Pharmacokinetics and dose recommendations for cyclosporine and tacrolimus when coadministered with ABT-450, ombitasvir, and dasabuvir. |
2015 |
Am. J. Transplant. |
pmid:25708713
|
Larson TS et al. |
Complete avoidance of calcineurin inhibitors in renal transplantation: a randomized trial comparing sirolimus and tacrolimus. |
2006 |
Am. J. Transplant. |
pmid:16468960
|
Vitko S et al. |
Tacrolimus combined with two different dosages of sirolimus in kidney transplantation: results of a multicenter study. |
2006 |
Am. J. Transplant. |
pmid:16468962
|
Woywodt A et al. |
Different preparations of tacrolimus and medication errors. |
2008 |
Am. J. Transplant. |
pmid:18786238
|
Servais A et al. |
Interstitial fibrosis evolution on early sequential screening renal allograft biopsies using quantitative image analysis. |
2011 |
Am. J. Transplant. |
pmid:21672152
|
Carenco C et al. |
Tacrolimus and the risk of solid cancers after liver transplant: a dose effect relationship. |
2015 |
Am. J. Transplant. |
pmid:25648361
|
Mulay AV et al. |
Impact of immunosuppressive medication on the risk of renal allograft failure due to recurrent glomerulonephritis. |
2009 |
Am. J. Transplant. |
pmid:19353768
|
Bourdeaux C et al. |
Living-related versus deceased donor pediatric liver transplantation: a multivariate analysis of technical and immunological complications in 235 recipients. |
2007 |
Am. J. Transplant. |
pmid:17173657
|
Heller T et al. |
Plasma concentrations of mycophenolic acid acyl glucuronide are not associated with diarrhea in renal transplant recipients. |
2007 |
Am. J. Transplant. |
pmid:17532750
|
Rostaing L et al. |
Alefacept combined with tacrolimus, mycophenolate mofetil and steroids in de novo kidney transplantation: a randomized controlled trial. |
2013 |
Am. J. Transplant. |
pmid:23730730
|
Posselt AM et al. |
Islet transplantation in type 1 diabetics using an immunosuppressive protocol based on the anti-LFA-1 antibody efalizumab. |
2010 |
Am. J. Transplant. |
pmid:20659093
|
Ciancio G et al. |
Advantage of rapamycin over mycophenolate mofetil when used with tacrolimus for simultaneous pancreas kidney transplants: randomized, single-center trial at 10 years. |
2012 |
Am. J. Transplant. |
pmid:22946986
|
Jacobson PA et al. |
Lower calcineurin inhibitor doses in older compared to younger kidney transplant recipients yield similar troughs. |
2012 |
Am. J. Transplant. |
pmid:22947444
|
De Simone P et al. |
Everolimus with reduced tacrolimus improves renal function in de novo liver transplant recipients: a randomized controlled trial. |
2012 |
Am. J. Transplant. |
pmid:22882750
|
Echeverri GJ et al. |
Endoscopic gastric submucosal transplantation of islets (ENDO-STI): technique and initial results in diabetic pigs. |
2009 |
Am. J. Transplant. |
pmid:19775318
|